Professor George Kirov

2024

• Walker, A. et al. 2024. Genome-wide copy number variation association study in anorexia nervosa. Molecular Psychiatry (10.1038/s41380-024-02811-2)
• Dinneen, T. J., Ní Ghrálaigh, F., Ormond, C., Heron, E. A., Kirov, G., Lopez, L. M. and Gallagher, L. 2024. Polygenic scores stratify neurodevelopmental copy number variant carrier cognitive outcomes in the UK Biobank. npj Genomic Medicine 9(1), article number: 43. (10.1038/s41525-024-00426-8)
• Shitomi-Jones, L. M., Dolman, C., Jones, I., Kirov, G., Escott-Price, V., Legge, S. E. and Di Florio, A. 2024. Exploration of first onsets of mania, schizophrenia spectrum disorders and major depressive disorder in perimenopause. nature mental health 2(10), pp. 1161-1168. (10.1038/s44220-024-00292-4)
• Legge, S. E. et al. 2024. Genetic and phenotypic features of Schizophrenia in the UK Biobank. JAMA Psychiatry 81, pp. 681-690. (10.1001/jamapsychiatry.2024.0200)
• Trastulla, L. et al. 2024. Distinct genetic liability profiles define clinically relevant patient strata across common diseases. Nature Communications 15, article number: 5534. (10.1038/s41467-024-49338-2)
• Stevenson-Hoare, J. et al. 2024. Severe psychiatric disorders are associated with increased risk of dementia. BMJ Mental Health 27(1), article number: e301097. (10.1136/bmjment-2024-301097)
• Ekstrand, J., Takamiya, A., Nordenskjold, A., Kirov, G., Sienaert, P., Kellner, C. H. and Movahed Rad, P. 2024. Ketamine or ECT? What have we learned from the KetECT and ELEKT-D trials?. International Journal of Neuropsychopharmacology 27(1), article number: pyad065. (10.1093/ijnp/pyad065)

2023

• Caseras, X., Legge, S., Bracher-Smith, M., Anney, R., Owen, M., Escott-Price, V. and Kirov, G. 2023. Copy Number Variants increasing risk for schizophrenia: shared and distinct effects on brain morphometry and cognitive performance. Biological Psychiatry: Global Open Science 3(4), pp. 902-911. (10.1016/j.bpsgos.2022.10.006)
• Wren, G. et al. 2023. Characterising heart rhythm abnormalities associated with Xp22.31 deletion. Journal of Medical Genetics 60, pp. 636-643. (10.1136/jmg-2022-108862)
• Lynham, A. J. et al. 2023. DRAGON-Data: A platform and protocol for integrating genomic and phenotypic data across large psychiatric cohorts. BJPsych Open 9(2), article number: e32. (10.1192/bjo.2022.636)
• Rammos, A., Kirov, G., Hubbard, L., Walters, J., Holmans, P., Owen, M. and Rees, E. 2023. Family-based analysis of the contribution of rare and common genetic variants to school performance in schizophrenia. Molecular Psychiatry 28, pp. 2081-2087. (10.1038/s41380-023-02013-2)

2022

• Bracher-Smith, M. et al. 2022. Machine learning for prediction of schizophrenia using genetic and demographic factors in the UK Biobank. Schizophrenia Research 246, pp. 156-164. (10.1016/j.schres.2022.06.006)
• Howells, D., Rees, J., Townsend, R. and Kirov, G. 2022. Electroconvulsive therapy reverses cerebral hypoperfusion in a patient with psychotic depression and catatonia. The Journal of ECT 38(2), pp. 141-143. (10.1097/YCT.0000000000000836)
• Brcic, L., Wren, G., Underwood, J., Kirov, G. and Davies, W. 2022. Comorbid medical issues in X-linked ichthyosis [Letter]. JID Innovations 2(3), article number: 100109. (10.1016/j.xjidi.2022.100109)
• Singh, T., Schizophrenia Exome Meta-Analysis (SCHEMA) Consortium, ., Kirov, G., Rees, E., Walters, J., Owen, M. and O'Donovan, M. 2022. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature 604, pp. 509-516. (10.1038/s41586-022-04556-w)
• Trubetskoy, V. et al. 2022. Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia. Nature 604, pp. 502-508. (10.1038/s41586-022-04434-5)
• Gardner, E. J. et al. 2022. Reduced reproductive success is associated with selective constraint on human genes. Nature 603(7903), pp. 858-863. (10.1038/s41586-022-04549-9)

2021

• Kalman, J. L. et al. 2021. Characterisation of age and polarity at onset in bipolar disorder. The British Journal of Psychiatry 219(6), pp. 659-669. (10.1192/bjp.2021.102)
• Kirov, G., Jauhar, S., Sienaert, P., Kellner, C. H. and McLoughlin, D. M. 2021. Electroconvulsive therapy for depression: 80 years of progress. British Journal of Psychiatry 219(5), pp. 594-597. (10.1192/bjp.2021.37)
• Rees, E. et al. 2021. Schizophrenia, autism spectrum disorders and developmental disorders share specific disruptive coding mutations. Nature Communications 12, article number: 5353. (10.1038/s41467-021-25532-4)
• Silva, A. I. et al. 2021. Analysis of diffusion tensor imaging data from the UK Biobank confirms dosage effect of 15q11.2 copy number variation on white matter and shows association with cognition. Biological Psychiatry 90(5), pp. 307-316. (10.1016/j.biopsych.2021.02.969)
• Clifton, N. E. et al. 2021. Genetic association of FMRP targets with psychiatric disorders. Molecular Psychiatry 26, pp. 2977-2990. (10.1038/s41380-020-00912-2)
• Hubbard, L. et al. 2021. Rare copy number variations are associated with poorer cognition in schizophrenia. Biological Psychiatry 90(1), pp. 28-34. (10.1016/j.biopsych.2020.11.025)
• Mullins, N. et al. 2021. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nature Genetics 53, pp. 817-829. (10.1038/s41588-021-00857-4)
• Rees, E. and Kirov, G. 2021. Copy number variation and neuropsychiatric illness. Current Opinion in Genetics and Development 68, pp. 57-63. (10.1016/j.gde.2021.02.014)
• Caseras, X. et al. 2021. Effects of genomic copy number variants penetrant for schizophrenia on cortical thickness and surface area in healthy individuals: analysis of the UK Biobank. British Journal of Psychiatry 218(2), pp. 104-111. (10.1192/bjp.2020.139)

2020

• Kendall, K. M. et al. 2020. Impact of schizophrenia genetic liability on the association between schizophrenia and physical illness: a data linkage study. BJPsych Open 6(6), article number: e139. (10.1192/bjo.2020.42)
• Soda, T. et al. 2020. International consortium on the genetics of electroconvulsive therapy and severe depressive disorders (Gen-ECT-ic). European Archives of Psychiatry and Clinical Neuroscience 270, pp. 921-932. (10.1007/s00406-019-01087-w)
• Brcic, L., Underwood, J., Kendall, K., Caseras, X., Kirov, G. and Davies, W. 2020. Medical and neurobehavioural phenotypes in carriers of X-linked ichthyosis-associated genetic deletions in the UK Biobank. Journal of Medical Genetics 57(10), pp. 692-698. (10.1136/jmedgenet-2019-106676)
• Gubb, S., Brcic, L., Underwood, J., Kendall, K., Caseras, X., Kirov, G. and Davies, W. 2020. Medical and neurobehavioural phenotypes in male and female carriers of Xp22.31 duplications in the UK Biobank. Human Molecular Genetics 29(17), pp. 2872-2881. (10.1093/hmg/ddaa174)
• Wong, H., Wadon, M., Evans, A., Kirov, G., Modi, N., O'Donovan, M. and Thapar, A. 2020. Contribution of de novo and inherited rare copy number variants to very preterm birth. Journal of Medical Genetics 57(8), pp. 552-557. (10.1136/jmedgenet-2019-106619)
• Akingbuwa, W. A. et al. 2020. Genetic associations between childhood psychopathology and adult depression and associated traits in 42 998 individuals. JAMA Psychiatry 77(7), pp. 715-728. (10.1001/jamapsychiatry.2020.0527)
• Legge, S. et al. 2020. Clinical indicators of treatment-resistant psychosis. British Journal of Psychiatry 216(5), pp. 259-266. (10.1192/bjp.2019.120)
• Martin, J. et al. 2020. A brief report: de novo copy number variants in children with attention deficit hyperactivity disorder. Translational Psychiatry 10, article number: 135. (10.1038/s41398-020-0821-y)
• Warland, A., Kendall, K. M., Rees, E., Kirov, G. and Caseras, X. 2020. Schizophrenia-associated genomic copy number variants and subcortical brain volumes in the UK Biobank. Molecular Psychiatry 25(4), pp. 854-862. (10.1038/s41380-019-0355-y)
• Szatkiewicz, J. P. et al. 2020. Characterization of single gene copy number variants in schizophrenia. Biological Psychiatry 87(8), pp. 736-744. (10.1016/j.biopsych.2019.09.023)
• Rees, E. et al. 2020. De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia. Nature Neuroscience 23(2), pp. 179-184. (10.1038/s41593-019-0565-2)

2019

• Legge, S. E. et al. 2019. Association of genetic liability to psychotic experiences with neuropsychotic disorders and traits. JAMA Psychiatry 76(12), pp. 1256-1265. (10.1001/jamapsychiatry.2019.2508)
• Lee, P. H. et al. 2019. Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell 179(7), pp. 1469-1482.e11. (10.1016/j.cell.2019.11.020)
• Escott-Price, V. et al. 2019. Polygenic risk for schizophrenia and season of birth within the UK Biobank cohort. Psychological Medicine 49(15), pp. 2499-2504. (10.1017/S0033291718000454)
• Escott-Price, V., Pardinas, A. F., Santiago, E., Walters, J., Kirov, G., Owen, M. J. and O'Donovan, M. C. 2019. The relationship between common variant schizophrenia liability and number of offspring in the UK Biobank. American Journal of Psychiatry 176(8), pp. 661-666. (10.1176/appi.ajp.2018.18020140)
• Romagnoni, A. et al. 2019. Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data. Scientific Reports 9(1), pp. -., article number: 10351. (10.1038/s41598-019-46649-z)
• Stahl, E. A. et al. 2019. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nature Genetics 51, pp. 793-803. (10.1038/s41588-019-0397-8)
• Kendall, K. M. et al. 2019. Cognitive performance and functional outcomes of carriers of pathogenic copy number variants: analysis of the UK Biobank. British Journal of Psychiatry 214(5), pp. 297-304. (10.1192/bjp.2018.301)
• Kendall, K. M. et al. 2019. Association of rare copy number variants with risk of depression. JAMA Psychiatry 76(8), pp. 818-825. (10.1001/jamapsychiatry.2019.0566)
• Rees, E. et al. 2019. Targeted sequencing of 10,198 samples confirms abnormalities in neuronal activity and implicates voltage-gated sodium channels in schizophrenia pathogenesis. Biological Psychiatry 85(7), pp. 554-562. (10.1016/j.biopsych.2018.08.022)
• Vadgama, N. et al. 2019. De novo single-nucleotide and copy number variation in discordant monozygotic twins reveals disease-related genes. European Journal of Human Genetics 27(7), pp. 1121-1133. (10.1038/s41431-019-0376-7)
• Crawford, K. et al. 2019. Medical consequences of pathogenic CNVs in adults: Analysis of the UK Biobank. Journal of Medical Genetics 56, pp. 131-138. (10.1136/jmedgenet-2018-105477)
• Escott-Price, V., Bracher-Smith, M., Menzies, G., Walters, J., Kirov, G., Owen, M. J. and O'Donovan, M. C. 2019. Genetic liability to schizophrenia is negatively associated with educational attainment in UK Biobank. Journal of Molecular Psychiatry, pp. -. (10.1038/s41380-018-0328-6)

2018

• Owen, D. et al. 2018. Effects of pathogenic CNVs on physical traits in participants of the UK Biobank. BMC Genomics 19(1), article number: 867. (10.1186/s12864-018-5292-7)
• Bakhsh, A. D. et al. 2018. An InDel in Phospholipase-C-B-1 is linked with euthyroid multinodular goiter. Thyroid 28(7), pp. 891-901. (10.1089/thy.2017.0312)
• Guyatt, A. L. et al. 2018. Association of copy number variation across the genome with neuropsychiatric traits in the general population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177(5), pp. 489-502. (10.1002/ajmg.b.32637)
• Ruderfer, D. M. et al. 2018. Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes. Cell 173(7), pp. 1705-1715.e16. (10.1016/j.cell.2018.05.046)
• Pardinas, A. F. et al. 2018. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nature Genetics 50, pp. 381-389. (10.1038/s41588-018-0059-2)

2017

• Green, E. K. et al. 2017. Genome-wide significant locus for Research Diagnostic Criteria Schizoaffective Disorder Bipolar type. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 174(8), pp. 767-771. (10.1002/ajmg.b.32572)
• Legge, S. E. et al. 2017. Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia. Molecular Psychiatry 22, pp. 1502-1508. (10.1038/mp.2016.97)
• Singh, T. et al. 2017. The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nature Genetics 49, pp. 1167-1173. (10.1038/ng.3903)
• Kendall, K. M. et al. 2017. Cognitive performance among carriers of pathogenic copy number variants: analysis of 152,000 UK Biobank subjects. Biological Psychiatry 82(2), pp. P103-110. (10.1016/j.biopsych.2016.08.014)
• Witt, S. H. et al. 2017. Genome-wide association study of borderline personality disorder reveals genetic overlap with the bipolar disorder, schizophrenia and major depression. Translational Psychiatry 7, article number: e1155.
• McLaughlin, R. L. et al. 2017. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nature Communications 8, article number: 14774. (10.1038/ncomms14774)
• Clifton, N. E. et al. 2017. Schizophrenia copy number variants and associative learning. Molecular Psychiatry 22(2), pp. 178-182. (10.1038/mp.2016.227)
• Marshall, C. R. et al. 2017. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nature Genetics 49, pp. 27-35. (10.1038/ng.3725)
• Kendall, K., Kirov, G. and Owen, M. 2017. Schizophrenia Genetics. In: Benjamin, S., Virginia, S. and Pedro, R. eds. Kaplan and Sadock?s Comprehensive Textbook of Psychiatry. Wolters Kluwer

2016

• Rees, E. et al. 2016. Analysis of intellectual disability copy number variants for association with schizophrenia. JAMA Psychiatry 73(9), pp. 963-969. (10.1001/jamapsychiatry.2016.1831)
• Tansey, K. E. et al. 2016. Common alleles contribute to schizophrenia in CNV carriers. Molecular Psychiatry 21, pp. 1085-1089. (10.1038/mp.2015.143)
• Pardinas, A. et al. 2016. Common schizophrenia alleles are enriched in mutation-intolerant genes and maintained by background selection. [Online]. bioRxiv. (10.1101/068593) Available at: http://dx.doi.org/10.1101/068593
• Han, J. et al. 2016. Gender differences in CNV burden do not confound schizophrenia CNV associations. Scientific Reports 6, article number: 25986. (10.1038/srep25986)
• Isles, A. R. et al. 2016. Parental origin of interstitial duplications at 15q11.2-q13.3 in schizophrenia and neurodevelopmental disorders. PLoS Genetics 12(5), article number: e1005993. (10.1371/journal.pgen.1005993)
• Singh, T. et al. 2016. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nature Neuroscience 19(4), pp. 571-577. (10.1038/nn.4267)
• Fry, A. E. et al. 2016. Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy. BMC Medical Genetics 17, pp. -., article number: 34. (10.1186/s12881-016-0294-2)
• Carroll, L. S. et al. 2016. Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation. Psychiatric Genetics 26(2), pp. 60-65. (10.1097/YPG.0000000000000110)
• Kirov, G. G. et al. 2016. Evaluation of cumulative cognitive deficits from electroconvulsive therapy. British Journal of Psychiatry 208(3), pp. 266-270. (10.1192/bjp.bp.114.158261)
• Franke, B. et al. 2016. Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nature Neuroscience 19(3), pp. 420-431. (10.1038/nn.4228)
• Singh, T. et al. 2016. Rare loss-of-function variants in KMT2F are associated with schizophrenia and developmental disorders. Nature Neuroscience 19, pp. 571-577. (10.1101/036384)
• Bigdeli, T. B. et al. 2016. Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 171(2), pp. 276-289. (10.1002/ajmg.b.32402)

2015

• Tansey, K. E. et al. 2015. Common alleles contribute to schizophrenia in CNV carriers [Erratum]. Molecular Psychiatry 21, article number: 1153. (10.1038/mp.2015.170)
• Escott-Price, V., Kirov, G., Rees, E., Isles, A. R., Owen, M. J. and O'Donovan, M. C. 2015. No evidence for enrichment in schizophrenia for common allelic associations at imprinted loci. PLoS ONE 10(12), pp. -., article number: e0144172. (10.1371/journal.pone.0144172)
• Kirov, G. 2015. CNVs in neuropsychiatric disorders. Human Molecular Genetics 24(R1), pp. R45-R49. (10.1093/hmg/ddv253)
• Lee, S. H. et al. 2015. New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. International Journal of Epidemiology 44(5), pp. 1706-1721. (10.1093/ije/dyv136)
• Pocklington, A. et al. 2015. Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia. Neuron 86(5), pp. 1203-1214. (10.1016/j.neuron.2015.04.022)
• Kirov, G., Rees, E. and Walters, J. T. R. 2015. What a psychiatrist needs to know about copy number variants. BJPscyh Advances 21(3), pp. 157-163. (10.1192/apt.bp.113.012039)
• Bulik-Sullivan, B. K. et al. 2015. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nature Genetics 47(3), pp. 291-295. (10.1038/ng.3211)
• O'Dushlaine, C. et al. 2015. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nature Neuroscience 18(2), pp. 199-209. (10.1038/nn.3922)
• Maier, R. et al. 2015. Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder. American Journal of Human Genetics 96(2), pp. 283-294. (10.1016/j.ajhg.2014.12.006)
• Green, E. K. et al. 2015. Copy number variation in bipolar disorder. Molecular Psychiatry 21(1), pp. 89-93. (10.1038/mp.2014.174)
• Rees, E. et al. 2015. Analysis of exome sequence in 604 trios for recessive genotypes in schizophrenia. Translational Psychiatry 5(7), article number: e607. (10.1038/tp.2015.99)

2014

• Peall, K. J. et al. 2014. SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. Journal of Neurology 261(12), pp. 2296-2304. (10.1007/s00415-014-7488-3)
• Georgieva, L. et al. 2014. De novo CNVs in bipolar affective disorder and schizophrenia. Human Molecular Genetics 23(24), pp. 6677-6683. (10.1093/hmg/ddu379)
• Gusev, A. et al. 2014. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. American Journal of Human Genetics 95(5), pp. 535-552. (10.1016/j.ajhg.2014.10.004)
• Szatkiewicz, J. P. et al. 2014. Copy number variation in schizophrenia in Sweden. Molecular Psychiatry 19(7), pp. 762-773. (10.1038/mp.2014.40)
• Ripke, S. et al. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511(7510), pp. 421-427. (10.1038/nature13595)
• Rees, E., Walters, J. T. R., Owen, M. J. and Kirov, G. 2014. Authors' reply [Letter]. British Journal of Psychiatry 205(1), pp. 78. (10.1192/bjp.205.1.78)
• Morris, D. W. et al. 2014. An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis. Human Molecular Genetics 23(12), pp. 3316-3326. (10.1093/hmg/ddu025)
• Rees, E. et al. 2014. CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Human Molecular Genetics 23(6), pp. 1669-1676. (10.1093/hmg/ddt540)
• Mulle, J. G. et al. 2014. Reciprocal duplication of the Williams-Beuren Syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. Biological Psychiatry 75(5), pp. 371-7. (10.1016/j.biopsych.2013.05.040)
• Rees, E. et al. 2014. Analysis of copy number variations at 15 schizophrenia-associated loci. British Journal of Psychiatry 204(2), pp. 108-114. (10.1192/bjp.bp.113.131052)
• Fromer, M. et al. 2014. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, pp. 179-184. (10.1038/nature12929)
• Hoeffding, L. K. E. et al. 2014. Sequence analysis of 17NRXN1deletions. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165(1), pp. 52-61. (10.1002/ajmg.b.32204)

2013

• Green, E. K. et al. 2013. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Molecular Psychiatry 18(12), pp. 1302-1307. (10.1038/mp.2012.142)
• van Scheltinga, A. F. T. et al. 2013. Schizophrenia genetic variants are not associated with intelligence. Psychological Medicine 43(12), pp. 2563-2570. (10.1017/S0033291713000196)
• Grozeva, D. et al. 2013. Reduced burden of very large and rare CNVs in bipolar affective disorder. Bipolar Disorders 15(8), pp. 893-8. (10.1111/bdi.12125)
• Rees, E. et al. 2013. Evidence that duplications of 22q11.2 protect against schizophrenia. Molecular Psychiatry n/a (10.1038/mp.2013.156)
• Ruderfer, D. et al. 2013. Mosaic copy number variation in schizophrenia. European Journal of Human Genetics 21(9), pp. 1007-1011. (10.1038/ejhg.2012.287)
• Lee, S. et al. 2013. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics 45(9), pp. 984-994. (10.1038/ng.2711)
• Lionel, A. C. et al. 2013. Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures. Human Molecular Genetics 22(10), pp. 2055-2066. (10.1093/hmg/ddt056)
• Kronenberg, F. et al. 2013. Novel Loci Associated with Increased Risk of Sudden Cardiac Death in the Context of Coronary Artery Disease [Article]. PLoS ONE 8(4), pp. e59905. (10.1371/journal.pone.0059905)
• Terwisscha van Scheltinga, A. F. et al. 2013. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biological Psychiatry 73(6), pp. 525-531. (10.1016/j.biopsych.2012.08.017)
• Guha, S. et al. 2013. Implication of a rare deletion at distal 16p11.2 in schizophrenia. JAMA Psychiatry 70(3), pp. 253-260. (10.1001/2013.jamapsychiatry.71)
• Williams, H. J., Monks, S., Murphy, K. C., Kirov, G., O'Donovan, M. C. and Owen, M. J. 2013. Schizophrenia two-hit hypothesis in velo-cardio facial syndrome. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162(2), pp. 177-182. (10.1002/ajmg.b.32129)
• Chapman, J. et al. 2013. A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk. Human Molecular Genetics 22(4), pp. 816-824. (10.1093/hmg/dds476)
• Betcheva, E. et al. 2013. Whole-genome-wide association study in the Bulgarian population reveals HHAT as schizophrenia susceptibility gene. Psychiatric Genetics 23(1), pp. 11-19. (10.1097/YPG.0b013e3283586343)
• Peall, K. J. et al. 2013. SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain 136(1), pp. 294-303. (10.1093/brain/aws308)
• Kim, Y. et al. 2013. Non-random mating, parent-of-origin, and maternal-fetal incompatibility effects in schizophrenia. Schizophrenia Research 143(1), pp. 11-17. (10.1016/j.schres.2012.11.002)
• Kirov, G. et al. 2013. The penetrance of copy number variations for schizophrenia and developmental delay. Biological Psychiatry 75(5), pp. 378-385. (10.1016/j.biopsych.2013.07.022)
• Aberg, K. A. et al. 2013. A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry 70(6), pp. 573-581. (10.1001/jamapsychiatry.2013.288)
• Betcheva, E. T. et al. 2013. Whole-genome-wide association study in the Bulgarian population reveals HHAT as schizophrenia susceptibility gene [Article]. Psychiatric Genetics 23(1), pp. 11-19. (10.1097/YPG.0b013e3283586343)
• Peall, K. et al. 2013. Are psychiatric symptoms a core phenotype of myoclonus dystonia syndrome caused by SGCE mutations?. Journal of Neurology, Neurosurgery & Psychiatry 84(9), article number: e1. (10.1136/jnnp-2013-306103.24)

2012

• Cooper, J. D. et al. 2012. Seven newly identified loci for autoimmune thyroid disease. Human Molecular Genetics 21(23), pp. 5202-5208. (10.1093/hmg/dds357)
• Jostins, L. et al. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491(7422), pp. 119-124. (10.1038/nature11582)
• Williams, H. J., Georgieva, L., Dwyer, S. L., Kirov, G., Owen, M. J. and O'Donovan, M. C. 2012. Absence of de novo point mutations in exons of GRIN2B in a large schizophrenia trio sample [Letter]. Schizophrenia Research 141(2-3), pp. 274-276. (10.1016/j.schres.2012.08.024)
• Fromer, M. et al. 2012. Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. American Journal of Human Genetics 91(4), pp. 597-607. (10.1016/j.ajhg.2012.08.005)
• Badner, J. A. et al. 2012. Genome-wide linkage analysis of 972 bipolar pedigrees using single-nucleotide polymorphisms. Molecular Psychiatry 17(8), pp. 818-826. (10.1038/mp.2011.89)
• Jia, P. et al. 2012. Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia. PLoS Computational Biology 8(7), article number: e1002587. (10.1371/journal.pcbi.1002587)
• Derks, E. M. et al. 2012. Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: A polygenic risk score analysis. PLoS ONE 7(6), article number: e37852. (10.1371/journal.pone.0037852)
• Rees, E., Kirov, G., O'Donovan, M. C. and Owen, M. J. 2012. De Novo mutation in schizophrenia. Schizophrenia Bulletin 38(3), pp. 377-381. (10.1093/schbul/sbs047)
• Kirov, G. and Miller, G. 2012. Creativity and mental disorder. British Journal of Psychiatry 200(4), pp. 347. (10.1192/bjp.200.4.347a)
• Keller, M. C. et al. 2012. Runs of homozygosity implicate autozygosity as a schizophrenia risk factor. Plos Genetics 8(4), article number: e1002656. (10.1371/journal.pgen.1002656)
• Grozeva, D. et al. 2012. Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophrenia Research 135(1-3), pp. 1-7. (10.1016/j.schres.2011.11.004)
• Kirov, G. et al. 2012. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Molecular Psychiatry 17(2), pp. 142-153. (10.1038/mp.2011.154)
• Jia, P. et al. 2012. A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. Journal of Medical Genetics 49(2), pp. 96-103. (10.1136/jmedgenet-2011-100397)
• Richards, A. et al. 2012. Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain. Molecular Psychiatry 17(2), pp. 193-201. (10.1038/mp.2011.11)
• Werge, T., Ingason, A., Kirov, G., Rujescu, D. and Sigurdsson, E. 2012. Response to Boot et al. [Letter]. American Journal of Psychiatry 169(1), pp. 97. (10.1176/appi.ajp.2011.11091382r)
• Forstbauer, L. M. et al. 2012. Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata. European Journal of Human Genetics 20(3), pp. 326-332. (10.1038/ejhg.2011.185)

2011

• Rees, E., Escott-Price, V., Owen, M. J., O'Donovan, M. C. and Kirov, G. 2011. De novo rates and selection of schizophrenia-associated copy number variants. Biological Psychiatry 70(12), pp. 1109-1114. (10.1016/j.biopsych.2011.07.011)
• Sklar, P. et al. 2011. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 [Letter]. Nature Genetics 43(10), pp. 977-983. (10.1038/ng.943)
• Ripke, S. et al. 2011. Genome-wide association study identifies five new schizophrenia loci [Letter]. Nature Genetics 43(10), pp. 969-976. (10.1038/ng.940)
• Chen, J. et al. 2011. Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia. Schizophrenia Research 131(1-3), pp. 43-51.
• Chen, J. et al. 2011. Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia. Schizophrenia Research 131(1-3), pp. 43-51. (10.1016/j.schres.2011.06.023)
• Williams, H. J. et al. 2011. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Molecular Psychiatry 16(4), pp. 429-441. (10.1038/mp.2010.36)
• Ingason, A. et al. 2011. Maternally derived microduplications at 15q11-q13: Implication of imprinted genes in psychotic illness. American Journal of Psychiatry 168(4), pp. 408-417. (10.1176/appi.ajp.2010.09111660)
• O'Dushlaine, C. et al. 2011. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Molecular Psychiatry 16(3), pp. 286-292. (10.1038/mp.2010.7)
• Reilly, M. P. et al. 2011. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. The Lancet 377(9763), pp. 383-392. (10.1016/S0140-6736(10)61996-4)
• Bridges, M. et al. 2011. Genetic classification of populations using supervised learning. PLoS ONE 6(5), article number: e14802. (10.1371/journal.pone.0014802)
• Hamshere, M. L. et al. 2011. Polygenic dissection of the bipolar phenotype. British Journal of Psychiatry 198(4), pp. 284-288. (10.1192/bjp.bp.110.087866)
• Green, E. K. et al. 2011. DISC1 exon 11 rare variants found more commonly in schizoaffective spectrum cases than controls. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156B(4), pp. 490-492. (10.1002/ajmg.b.31187)
• Smith, R. L. et al. 2011. Analysis of neurogranin (NRGN) in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156B(5), pp. 532-535. (10.1002/ajmg.b.31191)
• Carroll, L. S., Williams, H. J., Walters, J. T. R., Kirov, G., O'Donovan, M. C. and Owen, M. J. 2011. Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156(7), pp. 844-849. (10.1002/ajmg.b.31231)
• Yosifova, A. et al. 2011. Genome-wide association study on bipolar disorder in the Bulgarian population. Genes, Brain and Behavior 10(7), pp. 789-797. (10.1111/j.1601-183X.2011.00721.x)
• Ruderfer, D. M. et al. 2011. A family-based study of common polygenic variation and risk of schizophrenia [Letter]. Molecular Psychiatry 16(9), pp. 887-888. (10.1038/mp.2011.34)

2010

• Carroll, L. S. et al. 2010. Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha. Molecular Psychiatry 15(11), pp. 1101-1111. (10.1038/mp.2009.96)
• Craddock, N. J. et al. 2010. Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype [Corrigendum]. Molecular Psychiatry 15(11), pp. 1121-1121. (10.1038/mp.2010.62)
• Green, E. K. et al. 2010. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Molecular Psychiatry 15(10), pp. 1016-1022. (10.1038/mp.2009.49)
• Allison, D. B. et al. 2010. Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genetics 6(9), article number: e1001097. (10.1371/journal.pgen.1001097)
• Escott-Price, V. et al. 2010. Genetic differences between five European populations. Human Heredity 70(2), pp. 141-149. (10.1159/000313854)
• Grozeva, D. et al. 2010. Rare copy number variants: A point of rarity in genetic risk for bipolar disorder and schizophrenia. Archives of General Psychiatry 67(4), pp. 318-327. (10.1001/archgenpsychiatry.2010.25)
• Craddock, N. J. et al. 2010. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464(7289), pp. 713-720. (10.1038/nature08979)
• Craddock, N. J. et al. 2010. Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Molecular Psychiatry 15(2), pp. 146-153. (10.1038/mp.2008.66)
• Ikeda, M. et al. 2010. Copy number variation in schizophrenia in the Japanese population. Biological Psychiatry 67(3), pp. 283-286. (10.1016/j.biopsych.2009.08.034)
• Kirov, G. 2010. The role of copy number variation in schizophrenia. Expert Review of Neurotherapeutics 10(1), pp. 25-32. (10.1586/ern.09.133)
• Talkowski, M. E. et al. 2010. Fine-mapping reveals novel alternative splicing of the dopamine transporter. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B(8), pp. 1434-1447. (10.1002/ajmg.b.31125)
• Kirov, G. 2010. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. The Lancet 375(9712), pp. 385-395. (10.1016/S0140-6736(09)61828-6)
• Tredget, J., Kirov, A. and Kirov, G. 2010. Effects of chronic lithium treatment on renal function. Journal of affective disorders 126(3), pp. 436-440. (10.1016/j.jad.2010.04.018)
• Liu, Y. et al. 2010. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder [Letter]. Molecular Psychiatry 16(1), pp. 2-4. (10.1038/mp.2009.107)
• Chen, X. et al. 2010. GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Molecular Psychiatry 16(11), pp. 1117-1129. (10.1038/mp.2010.96)
• O'Dushlaine, C. T. et al. 2010. Population structure and genome-wide patterns of variation in Ireland and Britain. European Journal of Human Genetics 18(11), pp. 1248-1254. (10.1038/ejhg.2010.87)

2009

• Liu, Y. et al. 2009. Whole genome association study in a homogenous population in Shandong Peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia. Journal of Biomedicine and Biotechnology, article number: 536918. (10.1155/2009/536918)
• McCarthy, S. E. et al. 2009. Microduplications of 16p11.2 are associated with schizophrenia. Nature Genetics 41(11), pp. 1223-1227. (10.1038/ng.474)
• Orozco, G. et al. 2009. Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Human Molecular Genetics 18(14), pp. 2693-2699. (10.1093/hmg/ddp193)
• Li, Y. et al. 2009. An international collaborative family-based whole-genome linkage scan for high-grade myopia. Investigative Ophthalmology & Visual Science 50(7), pp. 3116-3127. (10.1167/iovs.08-2781)
• Raychaudhuri, S. et al. 2009. Identifying relationships among genomic disease regions: Predicting genes at pathogenic SNP associations and rare deletions. Plos Genetics 5(6), pp. -. (10.1371/journal.pgen.1000534)
• Kirov, G. et al. 2009. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Human Molecular Genetics 18(8), pp. 1497-1503. (10.1093/hmg/ddp043)
• O'Donovan, M. C. et al. 2009. Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Molecular Psychiatry 14(1), pp. 30-36. (10.1038/mp.2008.108)
• Hamshere, M. L. et al. 2009. Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. British Journal of Psychiatry 195(1), pp. 23-29. (10.1192/bjp.bp.108.061424)
• Purcell, S. M. et al. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256), pp. 748-752. (10.1038/nature08185)
• Talkowski, M. E. et al. 2009. Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B(4), pp. 560-569. (10.1002/ajmg.b.30862)
• Green, E. K. et al. 2009. P2RX7: A bipolar and unipolar disorder candidate susceptibility gene?. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B(8), pp. 1063-1069. (10.1002/ajmg.b.30931)
• Hamshere, M. L. et al. 2009. Age-at-onset in bipolar-I disorder: mixture analysis of 1369 cases identifies three distinct clinical sub-groups. Journal of affective disorders 116(1-2), pp. 23-29. (10.1016/j.jad.2008.10.021)
• Yosifova, A. et al. 2009. Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population. Journal of Affective Disorders 117(1-2), pp. 87-97. (10.1016/j.jad.2008.12.021)
• Kirov, G. and Owen, M. J. 2009. Genetics of schizophrenia. In: Sadock, B. J., Sadock, V. A. and Ruiz, P. eds. Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. 9th ed.., Vol. 1. Philadelphia: Lippincott Williams and Wilkins, pp. 1462-1474.
• Kirov, G., Rujescu, D., Ingason, A., Collier, D. A., O'Donovan, M. C. and Owen, M. J. 2009. Neurexin 1 (NRXN1) deletions in Schizophrenia. Schizophrenia Bulletin 35(5), pp. 851-854. (10.1093/schbul/sbp079)
• Hamshere, M. L. et al. 2009. Mood-incongruent psychosis in bipolar disorder: conditional linkage analysis shows genome-wide suggestive linkage at 1q32.3, 7p13 and 20q13.31. Bipolar Disorders 11(6), pp. 610-620. (10.1111/j.1399-5618.2009.00736.x)
• Kirov, G., Creaby, M., Khalid, N. and Atkins, M. 2009. Four years of successful maintenance electroconvulsive therapy [Letter]. The Journal of ECT 25(3), pp. 219-220. (10.1097/YCT.0b013e3181937f3d)
• Betcheva, E. T. et al. 2009. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. Journal of Human Genetics 54(2), pp. 98-107. (10.1038/jhg.2008.14)

2008

• Barton, A. et al. 2008. Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nature Genetics 40(10), pp. 1156-1159. (10.1038/ng.218)
• Abraham, R. et al. 2008. A genome-wide association study for late-onset Alzheimer's disease using DNA pooling. BMC Medical Genomics 1(1), article number: 44. (10.1186/1755-8794-1-44)
• Ferreira, M. A. R. et al. 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genetics 40(9), pp. 1056-1058. (10.1038/ng.209)
• Georgieva, L. et al. 2008. Support for Neuregulin 1 as a susceptibility gene for Bipolar disorder and schizophrenia. Biological psychiatry 64(5), pp. 419-427. (10.1016/j.biopsych.2008.03.025)
• Barton, A. et al. 2008. Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Human Molecular Genetics 17(15), pp. 2274-2279. (10.1093/hmg/ddn128)
• Loos, R. J. F. et al. 2008. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nature Genetics 40(6), pp. 768-775. (10.1038/ng.140)
• Fisher, S. A. et al. 2008. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nature Genetics 40(6), pp. 710-712. (10.1038/ng.145)
• Zaharieva, I., Georgieva, L., Nikolov, I., Kirov, G., Owen, M. J., O'Donovan, M. C. and Toncheva, D. 2008. Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping. BMC Psychiatry 8(1), pp. 11-11. (10.1186/1471-244X-8-11)
• Williams, N. M. et al. 2008. Strong evidence that GNB1L is associated with schizophrenia. Human Molecular Genetics 17(4), pp. 555-566. (10.1093/hmg/ddm330)
• Kirov, G. et al. 2008. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Human Molecular Genetics 17(3), pp. 458-465. (10.1093/hmg/ddm323)
• Kirov, G. et al. 2008. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Molecular Psychiatry 14(8), pp. 796-803. (10.1038/mp.2008.33)
• Stone, J. L. et al. 2008. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455(7210), pp. 237-241. (10.1038/nature07239)
• Kirov, G. et al. 2008. Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. The British Journal of Psychiatry 193(2), pp. 152-155. (10.1192/bjp.bp.107.044362)
• Khalid, N., Atkins, M., Tredget, J., Giles, M., Champney-Smith, K. and Kirov, G. 2008. The effectiveness of electroconvulsive therapy in treatment-resistant depression. The Journal of ECT 24(2), pp. 141-145. (10.1097/YCT.0b013e318157ac58)
• O'Donovan, M. C. et al. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics 40(9), pp. 1053-1055. (10.1038/ng.201)
• O'Donovan, M. C., Kirov, G. and Owen, M. J. 2008. Phenotypic variations on the theme of CNVs. Nature Genetics 40(12), pp. 1392-1393. (10.1038/ng1208-1392)

2007

• Nejentsev, S. et al. 2007. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450(7171), pp. 887-892. (10.1038/nature06406)
• Thomson, W. et al. 2007. Rheumatoid arthritis association at 6q23. Nature Genetics 39(12), pp. 1431-1433. (10.1038/ng.2007.32)
• Burton, P. R. et al. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145), pp. 661-678. (10.1038/nature05911)
• Nicholas, B., Rudrasingham, V., Nash, S., Kirov, G., Owen, M. J. and Wimpory, D. C. 2007. Association of Per1 and Npas2 with autistic disorder: support for the clock genes/social timing hypothesis. Molecular Psychiatry 12(6), pp. 581-592. (10.1038/sj.mp.4001953)
• Sisodiya, S. et al. 2007. Genetics of epilepsy: epilepsy research foundation workshop report. Epileptic Disorders 9(2), pp. 194-236.
• O'Donovan, M. C. et al. 2007. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia [Conference Abstract]. Schizophrenia bulletin 33(2), pp. 311-312. (10.1093/schbul/sbm004)
• Gunnell, D. et al. 2007. IGF1, growth pathway polymorphisms and schizophrenia: A pooling study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144B(1), pp. 117-120. (10.1002/ajmg.b.30396)
• Bell, V., Reddy, V., Halligan, P., Kirov, G. and Ellis, H. D. 2007. Relative suppression of magical thinking: A transcranial magnetic stimulation study. Cortex 43(4), pp. 551-557. (10.1016/S0010-9452(08)70249-1)
• Talkowski, M. E. et al. 2007. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Human Molecular Genetics 17(5), pp. 747-758. (10.1093/hmg/ddm347)
• Burton, P. R. et al. 2007. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics 39(11), pp. 1329-1337. (10.1038/ng.2007.17)

2006

• Glaser, B. et al. 2006. Analysis of ProDH, COMT and ZDHHC8 risk variants does not support individual or interactive effects on schizophrenia susceptibility. Schizophrenia Research 87(1-3), pp. 21. (10.1016/j.schres.2006.05.024)
• Khalid, N., Atkins, M. and Kirov, G. 2006. The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy. The Journal of ECT 22(3), pp. 184-88. (10.1097/01.yct.0000235931.24032.15)
• Georgieva, L. et al. 2006. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proceedings of the National Academy of Sciences of the United States of America (PNAS) ISSN 1091-6490 103(33), pp. 12469-12474. (10.1073/pnas.0603029103)
• Talkowski, M. E. et al. 2006. Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biological psychiatry 60(2), pp. 152-162. (10.1016/j.biopsych.2006.02.015)
• Williams, N. M. et al. 2006. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Archives of General Psychiatry 63(4), pp. 366-373. (10.1001/archpsyc.63.4.366)
• Kirov, G., Nikolov, I., Georgieva, L., Escott-Price, V., Owen, M. J. and O'Donovan, M. C. 2006. Pooled DNA genotyping on Affymetrix SNP genotyping arrays. BMC Genomics 7(1), pp. 27-37. (10.1186/1471-2164-7-27)
• Kirov, G. and Markov, G. 2006. Abdominal compartment syndrome. Khirurgiia 6, pp. 46-51.
• Lazarus, J. H., Kirov, G. and Harris, B. B. 2006. Effect of lithium on the thyroid and endocrine glands. In: Müller-Oerlinghausen, B., Bauer, M. and Grof, P. eds. Lithium in Neuropsychiatry : The Comprehensive Guide. Abingdon: Informa UK, pp. 259-270., (10.3109/9780203007051.022)
• Norton, N. et al. 2006. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141B(1), pp. 96-101. (10.1002/ajmg.b.30236)
• Lambert, D. et al. 2006. Stage 2 of the Wellcome Trust UK–Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16–q21, 4q12–q21, 9p21, 10p14–p12 and 18q22 - Corrigendum. Molecular Psychiatry 11(12), pp. 1140-1143. (10.1038/sj.mp.4001917)
• Green, E. K. et al. 2006. Evidence that a DISC1 frame-shift deletion associated with psychosis in a single family may not be a pathogenic mutation. Molecular Psychiatry 11(9), pp. 798-799. (10.1038/sj.mp.4001853)
• Blair, I. P. et al. 2006. Positional cloning, association analysis and expression studies provide convergent evidence that the cadherin gene FAT contains a bipolar disorder susceptibility allele. Molecular Psychiatry 11(4), pp. 372-383. (10.1038/sj.mp.4001784)
• Green, E. K. et al. 2006. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. British Journal of Psychiatry 188(1), pp. 21-25. (10.1192/bjp.bp.105.009969)
• Bakhsh, A., Kirov, G., Gregory, J. W., Williams, E. D. and Ludgate, M. E. 2006. A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer. Endocrine-Related Cancer 13(2), pp. 475-483. (10.1677/erc.1.01138)

2005

• Hamshere, M. L. et al. 2005. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Archives of general psychiatry 62(10), pp. 1081-1088. (10.1001/archpsyc.62.10.1081)
• Williams, H. J. et al. 2005. No association between schizophrenia and polymorphisms in COMT in two large samples. American Journal of Psychiatry 162(9), pp. 1736-1738. (10.1176/appi.ajp.162.9.1736)
• Kirov, G., Tredget, J., John, R., Owen, M. J. and Lazarus, J. H. 2005. A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients. Journal of affective disorders 87(2-3), pp. 313-317. (10.1016/j.jad.2005.03.010)
• Glaser, B. et al. 2005. No association between the putative functional ZDHHC8 single nucleotide polymorphism rs175174 and schizophrenia in large European samples. Biological psychiatry 58(1), pp. 78-80.
• Green, E. K. et al. 2005. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Archives of general psychiatry 62(6), pp. 642-648. (10.1001/archpsyc.62.6.642)
• Kirov, G., O'Donovan, M. C. and Owen, M. J. 2005. Finding schizophrenia genes. The Journal of Clinical Investigation 115(6), pp. 1440-1448. (10.1172/JCI24759)
• Tredget, J., Kirov, G. and Dunn, E. 2005. Transcranial magnetic stimulation for patients with depression. Nursing Standard 19(37), pp. 49-50. (10.7748/ns2005.05.19.37.49.c3876)
• Lambert, D. et al. 2005. Stage 2 of the Wellcome Trust UK-Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16-q21, 4q12-q21, 9p21, 10p14-p12 and 18q22. Molecular psychiatry 10(9), pp. 831-841. (10.1038/sj.mp.4001684)
• Tredget, J. and Kirov, G. 2005. Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series. BMC Psychiatry 5, pp. 19. (10.1186/1471-244X-5-19)
• Kirov, G., Tredget, J., Dunn, E., Escott-Price, V., Beer, R. and Khalid, N. 2005. Underpowered repetitive transcranial magnetic stimulation might not be an effective antidepressant treatment. Journal of Clinical Psychiatry 66(4), pp. 543.
• Glaser, B., Kirov, G., Green, E., Craddock, N. J. and Owen, M. J. 2005. Linkage disequilibrium mapping of bipolar affective disorder at 12q23-q24 provides evidence for association at CUX2 and FLJ32356. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 132B(1), pp. 38-45. (10.1002/ajmg.b.30081)
• Dimitrova, A., Milanova, V., Krastev, S., Nikolov, I., Toncheva, D., Owen, M. J. and Kirov, G. 2005. Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.. The Pharmacogenomics Journal 5(1), pp. 35-41. (10.1038/sj.tpj.6500273)
• Glaser, B., Kirov, G., Bray, N. J., Green, E., O'Donovan, M. C., Craddock, N. J. and Owen, M. J. 2005. Identification of a potential Bipolar risk haplotype in the gene encoding the winged-helix transcription factor RFX4. Molecular Psychiatry 10(10), pp. 920-927. (10.1038/sj.mp.4001689)
• Raybould, R. et al. 2005. Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biological psychiatry 57(7), pp. 696-701. (10.1016/j.biopsych.2005.01.018)
• Green, E. et al. 2005. Localization of bipolar susceptibility locus by molecular genetic analysis of the chromosome 12q23-q24 region in two pedigrees with bipolar disorder and Darier's disease. American Journal of Psychiatry 162(1), pp. 35-42. (10.1176/appi.ajp.162.1.35)

2004

• Farbrother, J. E., Kirov, G., Owen, M. J. and Guggenheim, J. A. 2004. Family aggregation of high myopia: estimation of the sibling recurrence risk ratio. Investigative Ophthalmology and Visual Science 45(9), pp. 2873-2878. (10.1167/iovs.03-1155)
• Farbrother, J. E., Kirov, G., Owen, M. J., Pong-Wong, R., Haley, C. S. and Guggenheim, J. A. 2004. Linkage analysis of the genetic loci for high myopia on chromosomes 18p, 12q and 17q in 51 UK families. Investigative Ophthalmology and Visual Science 45(9), pp. 2879-2885. (10.1167/iovs.03-1156)
• Norton, N. et al. 2004. Interaction between neuregulin 1 and its receptor ERBB4 increases susceptibility to schizophrenia [Conference Abstract]. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 130B(1), pp. 18-18.
• Craddock, N. J., Jones, I. R., Kirov, G. and Jones, L. 2004. The Bipolar Affective Disorder Dimension Scale (BADDS)--a dimensional scale for rating lifetime psychopathology in bipolar spectrum disorders. BMC Psychiatry 4, pp. 19-19. (10.1186/1471-244X-4-19)
• Kirov, G. et al. 2004. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biological psychiatry 55(10), pp. 971-975. (10.1016/j.biopsych.2004.01.025)
• Turic, D., Langley, K., Kirov, G., Owen, M. J., Thapar, A. and O'Donovan, M. C. 2004. Direct analysis of the genes encoding G proteins G alpha T2, G alpha o, G alpha Z in ADHD. American Journal of Medical Genetics 127B(1), pp. 68-72. (10.1002/ajmg.b.20173)
• Williams, N. M. et al. 2004. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Archives of General Psychiatry 61(4), pp. 336-344. (10.1001/archpsyc.61.4.336)
• Williams, N. M. et al. 2004. Support for RGS4 as a susceptibility gene for schizophrenia. Biological Psychiatry 55(2), pp. 192-195. (10.1016/j.biopsych.2003.11.002)
• Williams, N. M. et al. 2004. Identification in two independent samples of a novel schizophrenia risk haplotype of the dystobrevin binding protein gene (DTNBP1). Archives of general psychiatry 61(4), pp. 336-344. (10.1001/archpsyc.61.4.336)
• Cichon, S. et al. 2004. Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin. Nature Genetics 36(8), pp. 783-784. (10.1038/ng0804-783)

2003

• Ivanov, D. et al. 2003. Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis: Molecular genetic study. The British Journal of Psychiatry 183(5), pp. 409-413. (10.1192/bjp.183.5.409)
• Kirov, G. et al. 2003. Variation in the protocadherin - A gene cluster?. Genomics 82(4), pp. 433-440. (10.1016/S0888-7543(03)00167-8)
• Williams, H. et al. 2003. Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia. American Journal of Medical Genetics 120B(1), pp. 42-46. (10.1002/ajmg.b.20049)
• Williams, H. J. et al. 2003. Association between PRODH and schizophrenia is not confirmed. Molecular Psychiatry 8(7), pp. 644-645. (10.1038/sj.mp.4001276)
• Kirov, G. and Korszun, A. 2003. The antidepressant debate should move on. British Journal of Psychiatry 182(6), pp. 551-551. (10.1192/bjp.182.6.551)
• Georgieva, L., Nikolov, I., Poriazova, N., Jones, G., Toncheva, D., Kirov, G. and Owen, M. J. 2003. Genetic variation in the seven-pass transmembrane cadherin CELSR1. Psychiatric Genetics 13(2), pp. 103-106. (10.1097/01.ypg.0000057486.14812.03)
• Kirov, G. et al. 2003. Association analysis of the HOPA12bp polymorphism in schizophrenia and manic depressive illness. American Journal of Medical Genetics 118B(1), pp. 16-19. (10.1002/ajmg.b.10065)
• Farbrother, J. E., Kirov, G., Owen, M. J. and Guggenheim, J. A. 2003. Linkage analysis of 18p, 12q and 17q high myopia loci in 51 UK families. Investigative ophthalmology & visual science 44(E-Abst)
• Børglum, A. et al. 2003. Possible parent-of-origin effect of Dopa decarboxylase in susceptibility to bipolar affective disorder. American Journal of Medical Genetics 117B(1), pp. 18-22. (10.1002/ajmg.b.10030)

2002

• Bray, N. J. et al. 2002. Screening the protocadherin 8 (PCDH8) gene in schizophrenia [Conference Abstract]. American Journal of Medical Genetics 114(7), pp. 844-844.
• Dimitrova, A. et al. 2002. Major psychiatric disorders and the serotonin transporter gene (SLC6A4): family-based association studies. Psychiatric Genetics 12(3), pp. 137-141. (10.1097/00041444-200209000-00004)
• Bray, N. J. et al. 2002. Screening the human protocadherin 8 (PCDH8) gene in schizophrenia. Genes, Brain and Behavior 1(3), pp. 187-191. (10.1034/j.1601-183X.2002.10307.x)
• Norton, N. et al. 2002. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: No evidence for association or epistasis. American Journal Of Medical Genetics Part A 114(5), pp. 491-496. (10.1002/ajmg.10517)
• Georgieva, L. et al. 2002. Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: family-based association study in the Bulgarian population. Acta Psychiatrica Scandinavica 105(5), pp. 396-399. (10.1034/j.1600-0447.2002.1o174.x)
• Norton, N. et al. 2002. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Human Genetics 110(5), pp. 471-478. (10.1007/s00439-002-0706-6)
• Kirov, G. 2002. Use of a lithium analyzer machine in a mood disorders clinics. Journal of affective disorders 68(1), pp. 120-120.
• Williams, N. M. et al. 2002. Mutation screening and LD mapping in the VCFS deleted region of chromosome 22q11 in schizophrenia using a novel DNA pooling approach. Molecular Psychiatry 7(10), pp. 1092-1100. (10.1038/sj.mp.4001188)
• Sklar, P. et al. 2002. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Molecular Psychiatry 7(6), pp. 579. (10.1038/sj.mp.4001058)
• Bennett, P. et al. 2002. The Wellcome trust UK-Irish bipolar affective disorder sibling-pair genome screen: first stage report. Molecular Psychiatry 7(2), pp. 189-200. (10.1038/sj.mp.4000957)
• O'Mahony, E. et al. 2002. Sibling pairs with affective disorders: resemblance of demographic and clinical features. Psychological Medicine 32(1), pp. 55-61. (10.1017/S0033291701004986)

2001

• Kirov, G., Lowry, C. A., Stephens, M., Oldfield, S., O'Donovan, M. C., Lightman, S. L. and Owen, M. J. 2001. Screening ABCG1, the human homologue of the Drosophila white gene, for polymorphisms and association with bipolar affective disorder. Molecular Psychiatry 6(6), pp. 671-677. (10.1038/sj.mp.4000899)
• Stephens, M., Kirov, G. and Owen, M. J. 2001. ADARB1, a brain specific member of the RNA-specific adenosine deaminase family and bipolar affective disorder. American Journal of Medical Genetics 105(7), pp. 622-622.
• Kirov, G., Stehens, M. and Owen, M. J. 2001. Screening of three candidate genes in the bipolar candidate region on chromosome 21q22.3. American Journal of Medical Genetics 105(7), pp. 612-612.
• Williams, H., Kirov, G., Meyer, J., Lesch, K. P. and Owen, M. J. 2001. Further analysis of KIAA0027 in schizophrenic patients. American Journal of Medical Genetics 105(7), pp. 561-561.

2000

• Bowen, T. et al. 2000. No evidence of association from transmission disequilibrium analysis of the hKCa3 gene in bipolar disorder. Bipolar Disorders 2(4), pp. 328-331. (10.1034/j.1399-5618.2000.020406.x)
• Kirov, G., Stephens, M. and Owen, M. J. 2000. Examining the 4p16 region for association with bipolar disorder using DNA pooling. American Journal of Medical Genetics 96(4), pp. 548-548.
• O'Mahony, E. et al. 2000. Clinical similarities in siblings with bipolar disorder. American Journal of Medical Genetics 96(4), pp. 514-514.
• Kirov, G., Nikolov, I., Milanova, V., Roglev, M. and Jivkov, L. 2000. Comparison between clinical and demographic characteristics of bipolar patients collected in two different countries.. American Journal of Medical Genetics 96(4), pp. 506-506.
• Guggenheim, J. A., Kirov, G. and Hodson, S. A. 2000. The heritability of high myopia: a reanalysis of Goldschmidt's data. Journal of Medical Genetics 37(3), pp. 227-231. (10.1136/jmg.37.3.227)
• Kirov, G., Stephens, M., Williams, N. M., O'Donovan, M. C. and Owen, M. J. 2000. Automated genotyping of single-nucleotide polymorphisms by extension of fluorescently labelled primers: analysis of individual and pooled DNA samples. Balkan Journal of Medical Genetics 3, pp. 23-28.
• Kirov, G., Williams, N. M., Sham, P., Craddock, N. J. and Owen, M. J. 2000. Pooled genotyping of microsatellite markers in parent-offspring trios. Genome Research 10(1), pp. 105-115.
• Hoogendoorn, B. et al. 2000. Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools. Human Genetics 107(5), pp. 488-493. (10.1007/s004390000397)

1999

• Kirov, G., Norton, N., Jones, I. R., McCandless, F., Craddock, N. J. and Owen, M. J. 1999. A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder. International Journal of Neuropsychopharmacology 2(4), pp. 293-298. (10.1017/s1461145799001601)
• Borglum, A. D. et al. 1999. Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder. Molecular Psychiatry 4(6), pp. 545-551. (10.1038/sj.mp.4000559)
• Kirov, G., Jones, I. R., McCandless, F., Craddock, N. J. and Owen, M. J. 1999. Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5. Molecular Psychiatry 4(6), pp. 558-565.
• Kirov, G. and Owen, M. J. 1999. Identification of new microsatellite markers on chromosome 4p16. American Journal of Human Genetics 65(4), pp. A257-A257.
• Bowen, T. et al. 1999. Linkage studies of bipolar disorder with chromosome 18 markers. American Journal of Medical Genetics 15(88), pp. 503-509. (10.1002/(SICI)1096-8628(19991015)88:5<503::AID-AJMG13>3.0.CO;2-U)
• Petouni, M., Bolonna, A. A., Arranz, M. J., Martinez, M. J., Collier, D. A., Kirov, G. and Kerwin, R. W. 1999. Association study between genetic variants in the alpha- adrenergic receptor genes and bipolar affective disorder. Molecular Psychiatry 4, pp. S112-S112.
• Borglum, A. D. et al. 1999. Association study of the DOPA decarboxylase gene in bipolar affective disorder and schizophrenia. Molecular Psychiatry 4, pp. S103-S104.
• Birkett, J. T. P., Kirov, G., Arranz, M. J., Murray, R. M., Collier, D. A. and Kerwin, R. W. 1999. Association between a 2030-G/A substitution in the human myo-inositol monophosphatase gene (IMPA) and bipolar disorder and schizophrenia. Molecular Psychiatry 4, pp. S103-S103.
• Kirov, G., Rees, M., Jones, I. R., McCandless, F., Owen, M. J. and Craddock, N. J. 1999. Bipolar disorder and the serotonin transporter gene: a family-based association study. Psychological Medicine -London- 29(5), pp. 1249-1254. (10.1017/s003329179900882x)
• Williams, N. M., Bowen, T., Kirov, G., Williams, H., Hoogendorn, B., Asherson, P. and Owen, M. J. 1999. Polymorphism screening and association studies of the Wolfram syndrome gene in schizophrenia. Molecular Psychiatry 4(supp1), pp. S42-S42.
• Kirov, G. and Murray, R. M. 1999. Ethnic differences in the presentation of bipolar affective disorder. European Psychiatry 14(4), pp. 199-204.
• Li, T. et al. 1999. Association analysis between dopamine receptor genes and bipolar affective disorder. Psychiatry Research 86(3), pp. 193-201. (10.1016/S0165-1781(99)00034-7)
• Bolonna, A. A., Markoff, A. J., Munro, J., Kirov, G. and Kerwin, R. W. 1999. An investigation of a structural polymorphism in the mGluR7 gene in association with schizophrenia. Schizophrenia Research 36(1-3), pp. 99-99.
• Kirov, G., Owen, M. J., Jones, I., McCandless, F. and Craddock, N. J. 1999. Tryptophan hydroxylase gene and manic-depressive illness [letter]. Archives of General Psychiatry 56(1), pp. 98-99. (10.1001/archpsyc.56.1.98)

1998

• Kirov, G., Jones, I. R., McCandless, F., Craddock, N. J. and Owen, M. J. 1998. Family-based association studies of candidate genes in bipolar disorder. American Journal of Medical Genetics 81(6), pp. 476-477.
• Williams, N. M., Kirov, G., Craddock, N. J. and Owen, M. J. 1998. Screening the critical region on chromosome 4p with DNA pooling for association with bipolar disorder. American Journal of Medical Genetics 81(6), pp. 486-486.
• Birkett, J. T. P., Kirov, G., Powell, J., Murray, R. M., Kerwin, R. W. and Collier, D. A. 1998. No association between a variable number of tandem repeat (VNTR) in the 3 ' untranslated region of the dopamine transporter gene (DAT1) and bipolar affective disorder. American Journal of Medical Genetics 81(6), pp. 500-501.
• Kaneva, R. et al. 1998. A linkage study of affective disorders in two Bulgarian Gypsy families: results for candidate regions on chromosomes 18 and 21. Psychiatric Genetics 8(4), pp. 245-249. (10.1097/00041444-199808040-00008)
• Arranz, M. J., Munro, J., Sham, P., Kirov, G., Murray, R. M., Collier, D. A. and Kerwin, R. W. 1998. Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophrenia Research 32(2), pp. 93-99. (10.1016/S0920-9964(98)00032-2)
• Kirov, G. 1998. Thyroid disorders in lithium-treated patients. Journal of affective disorders 50(1), pp. 33-40.
• Kirov, G. et al. 1998. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Molecular Psychiatry 3(4), pp. 342-345. (10.1038/sj.mp.4000385)
• Kemp, R., Kirov, G., Everitt, B., Hayward, P. and David, A. 1998. Randomised controlled trial of compliance therapy. 18-month follow-up. British Journal of Psychiatry 172, pp. 413-419. (10.1192/bjp.172.5.413)
• Healey, A., Knapp, M., Astin, J., Beecham, J., Kemp, R., Kirov, G. and David, A. 1998. Cost-effectiveness evaluation of compliance therapy for people with psychosis. British Journal of Psychiatry 172, pp. 420-424. (10.1192/bjp.172.5.420)
• Holmes, C., Russ, C., Kirov, G., Aitchison, K. J., Powell, J. F., Collier, D. A. and Lovestone, S. 1998. Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease. Biological psychiatry 43(3), pp. 159-164. (10.1016/S0006-3223(97)00326-0)
• Padareva, V., Djoumaliisky, S., Touleshkov, N. and Kirov, G. 1998. Modification of blowing agent system based on sodium bicarbonate with activated natural zeolite. Journal of Materials Science Letters 17(2), pp. 107-109.
• Kirov, G., Kemp, R., Kirov, K. and David, A. S. 1998. Religious faith after psychotic illness. Psychopathology 31(5), pp. 234-245. (10.1159/000029045)
• Arranz, M. J. et al. 1998. Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Molecular Psychiatry 3(1), pp. 61-66. (10.1038/sj.mp.4000348)
• David, A. S., Kemp, R., Kirov, G., Everitt, B. and Hayward, P. 1998. Improving insight and compliance: Predictions and consequences. Schizophrenia Research 29(1-2), pp. 34-35. (10.1016/S0920-9964(97)88375-2)
• Arranz, M. J., Munro, J., Collier, D. A., Kirov, G. and Kerwin, R. W. 1998. Genetic variation in the 5-HT3 receptor gene: No association with schizophrenia or drug response. Schizophrenia Research 29(1-2), pp. 127-128.
• Arranz, M. J., Munro, J., Li, T., Collier, D. A., Kirov, G. and Kerwin, R. W. 1998. A polymorphism in the promoter region of the dopamine D2 receptor gene (DRD2) and drug response: Association studies. Schizophrenia Research 29(1-2), pp. 127-127.
• Vallada, H. P. et al. 1998. Linkage analysis between bipolar affective disorder and markers on chromosome X. Psychiatric Genetics 8(3), pp. 183-186. (10.1097/00041444-199800830-00008)

1997

• Dawson, E., Kirov, G., Hutchison, G., Murray, R. and Powell, J. F. 1997. The brain cannabinoid receptor gene and bipolar affective disorders. American Journal of Medical Genetics 74(6), pp. 613-614.
• Arranz, M. J., Munro, J., Kirov, G., Kerwin, R. W. and Collier, D. A. 1997. Novel polymorphisms detected in the 5-HT3 receptor gene: Association studies with schizophrenia and clozapine response. American Journal of Medical Genetics 74(6), pp. 615-615.
• Craddock, N. J., Jones, I. R., McCandless, F., Kirov, G. and Cardno, A. G. 1997. Dimensional classification for use in biological studies of bipolar disorder. American Journal of Medical Genetics 74(6), pp. 588-588.
• Bolonna, A. A., Makoff, A. J., Collier, D. A., Kirov, G., Arranz, M. J. and Kerwin, R. W. 1997. Analysis of the NMDA receptor in schizophrenia. American Journal of Medical Genetics 74(6), pp. 631-631.
• Vallada, H. P. et al. 1997. Linkage studies in bipolar affective disorder with markers on chromosome Xq25-27. American Journal of Medical Genetics 74(6), pp. 679-680.
• Kunugi, H. et al. 1997. No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene. Biological psychiatry 42(4), pp. 282-285. (10.1016/S0006-3223(96)00366-6)
• Kirov, G., Murray, R. M., Seth, R. V. and Feeney, S. 1997. Observations on switching patients with schizophrenia to risperidone treatment. Risperidone Switching Study Group. Acta Psychiatrica Scandinavica 95(5), pp. 439-443. (10.1111/j.1600-0447.1997.tb09659.x)
• Arranz, M. J. et al. 1997. 5-HT2A receptor and bipolar affective disorder: association studies in affected patients. Neuroscience Letters 224(2), pp. 95-98. (10.1016/S0304-3940(97)13456-5)
• Kirov, G. and Murray, R. 1997. The molecular genetics of schizophrenia: progress so far. Molecular Medicine Today 3(3), pp. 124-130. (10.1016/S1357-4310(96)10060-5)
• Arranz, M. et al. 1997. Polymorphisms in the 5-HT2A receptor gene and promoter region associated with clozapine response. Schizophrenia Research 24(1-2), pp. 90. (10.1016/S0920-9964(97)82243-8)
• Sodhi, M. S., Kirov, G., Aitchison, K. J., Arranz, M. J., Collier, D. A. and Kerwin, R. W. 1997. Allelic variation of the 5-HT2C receptor in psychosis. Schizophrenia Research 24(1-2), pp. 90. (10.1016/S0920-9964(97)82246-3)
• Bolonna, A., Makoff, A., Collier, D., Kirov, G., Munro, J., Arranz, M. and Kerwin, R. 1997. An investigation of the GLUR6 receptor gene (GRIK2) in schizophrenia. Schizophrenia Research 24(1-2), pp. 93. (10.1016/S0920-9964(97)82252-9)
• Li, T. et al. 1997. Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. NeuroReport 8(3), pp. 683-686. (10.1097/00001756-199702100-00021)

1996

• Collier, D. A. et al. 1996. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Molecular Psychiatry 1(6), pp. 453-460.
• Vallada, H. et al. 1996. Linkage studies in bipolar affective disorder with markers on chromosome 21. Journal of affective disorders 41(3), pp. 217-221. (10.1016/s0165-0327(96)00055-9)
• Arranz, M. J. et al. 1996. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neuroscience Letters 217(2-3), pp. 177-178. (10.1016/0304-3940(96)13094-9)
• Collier, D. A. et al. 1996. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. NeuroReport 7(10), pp. 1675-1679. (10.1097/00001756-199607080-00030)
• Kirov, G. et al. 1996. Do obstetric complications cause the earlier age at onset in male than female schizophrenics?. Schizophrenia Research 20(1-2), pp. 117-124. (10.1016/0920-9964(95)00063-1)
• Arranz, M., Kirov, G., Sodhi, M., Ball, D., Kerwin, R. and Collier, D. 1996. 5-HT2A polymorphisms and mental disorders. Schizophrenia Research 18(2-3), pp. 164. (10.1016/0920-9964(96)85523-X)
• Sodhi, M. S., Kirov, G., Arranz, M. J., Ball, D. M., Aitchison, K. J., Kerwin, R. W. and Collier, D. A. 1996. Association between psychoses and allelic variation in the 5-HT2C receptor gene. Schizophrenia Research 18(2-3), pp. IXB2.
• Kemp, R., Kirov, G., Hayward, P. and David, A. 1996. A randomised controlled trial of compliance therapy in psychosis: Follow-up results and predictors of outcome. Schizophrenia Research 18(2-3), pp. 135. (10.1016/0920-9964(96)85452-1)

1994

• Kirov, G., Jones, P. and Murray, R. 1994. Disappearance of gender differences in age at onset in schizophrenics with a familial loading. Acta Psychiatrica Scandinavica 90(3), pp. 236-237. (10.1111/j.1600-0447.1994.tb01583.x)
• Kirov, G., Jones, P. and Lewis, S. 1994. Prevalence of Delusional Misidentification Syndromes. Psychopathology 27(3-5), pp. 148-149. (10.1159/000284862)
• Kirov, G., Birch, J., Steadman, P. and Ramsey, G. 1994. Plasma magnesium levels in a population of psychiatric patients: correlations with symptoms. Neuropsychobiology 30(2-3), pp. 73-78. (10.1159/000119139)

1990

• Kirov, G. 1990. Slowly progressive schizophrenia. British Journal of Psychiatry 157, pp. 457-457.
• Kirov, G. and Tsachev, K. N. 1990. Magnesium, Schizophrenia and Manic-Depressive Disease. Neuropsychobiology 23(2), pp. 79-81. (10.1159/000119431)

1987

• Nikolova, S., Vinarova, M., Kirov, G. and Bradvarova, I. 1987. [In vitro research on the interaction of natural zeolites with diploid cells from the human embryonic lung].. Problemi Na Khigienata 12, pp. 133-141.